Skip to content

The application value of artificial intelligent breast ultrasound diagnostic system AIBUS in the diagnosis of breast diseases

The application value of artificial intelligent breast ultrasound diagnostic system AIBUS in the diagnosis of breast diseases

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032951
Enrollment
Unknown
Registered
2020-05-16
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mammary gland disease

Interventions

Gold Standard:Pathological examination results of tissue biopsy
Index test:1.&#32
Artificial&#32
Intelligent&#32
Ultrasound,AIBUS
2.&#32

Sponsors

Union Shenzhen Hospital, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Female; 2. Patients aged 25-64 years; 3. Patients who have informed consent and signed the informed consent approved by the ethics committee of Nanshan District People's Hospital of Shenzhen.

Exclusion criteria

Exclusion criteria: 1. Patients with broken chest skin; 2. Patients who have a history of breast cancer and have received treatment; 3. Patients who have undergone breast surgery; 4. Patients who have undergone breast augmentation; 5. Pregnancy; 6. Patients in lactation.

Design outcomes

Primary

MeasureTime frame
kappa value;

Secondary

MeasureTime frame
accuracy;

Countries

China

Contacts

Public ContactLiu Yao

Nanshan District People's Hospital, Shenzhen City

1254540250@qq.com+86 13537692804

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026